3-iodobenzylguanidine has been researched along with Vasculitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelkefi, C; Abida, R; Belhassen, A; Bouslama, K; El Ouni, A; Hamzaoui, S; Larbi, T; Meddeb, Z; Toujani, S | 1 |
| Hanaoka, M; Koizumi, T; Kubo, K; Urushihata, K; Yoshiike, F | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Vasculitis
| Article | Year |
|---|---|
Pheochromocytoma presenting as an authentic small vessel vasculitis and complicated with pulmonary embolism: An original presentation.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Diagnosis, Differential; Female; Hemorrhage; Humans; Iodine Radioisotopes; Myocarditis; Myositis; Pheochromocytoma; Pulmonary Alveoli; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed; Vasculitis | 2021 |
Reduced lung uptake of iodine-123 metaiodobenzylguanidine in patients with myeloperoxidase antineutrophil cytoplasmic antibodies-positive vasculitis.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Endothelium, Vascular; Female; Humans; Kidney Diseases; Lung; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Vasculitis | 2006 |